Airway Epithelial Cell Peroxisome Proliferator-Activated Receptor γ Regulates Inflammation and Mucin Expression in Allergic Airway Disease.
Airway Epithelial Cell Peroxisome Proliferator-Activated Receptor γ Regulates Inflammation and Mucin Expression in Allergic Airway Disease.
复制标题
DOI:
10.4049/jimmunol.1800649
复制
发表时间:
2018-09-15
期刊:
影响因子:
--
通讯作者:
Reddy RC
中科院分区:
文献类型:
--
作者:
Lakshmi SP;Reddy AT;Banno A;Reddy RC
Airway epithelial cells (AECs) orchestrate inflammatory responses to airborne irritants that enter the respiratory system. A viscous mucus layer produced by goblet cells in the airway epithelium also contributes to a physiological defense mechanism through the physical and chemical barriers it provides. Dysregulation or impairment in these functions has been implicated as a cause of the chronic inflammation and tissue remodeling that constitute major pathological features of asthma. In particular, mucus hypersecretion leading to airway obstruction and impaired pulmonary function is associated with morbidity and mortality in asthma patients. Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription factor involved in a variety of cellular processes. Accumulating evidence indicates that PPARγ agonists antagonize exaggerated inflammatory responses, yet PPARγ’s precise role in airway remodeling/mucus hypersecretion has yet to be defined. In this study, we created an AEC-specific PPARγ deletion to investigate PPARγ’s functions in a murine model of allergic airway disease. AEC-specific PPARγ deficiency exaggerated airway hyperresponsiveness, inflammation, cytokine expression, and tissue remodeling. We also found that PPARγ directly bound to a PPAR response element found in MUC5AC and repressed gene expression. Likewise, PPARγ regulated mucin and inflammatory factors in primary human bronchial epithelial cells. In light of the current standard therapies’ limited and inadequate direct effect on airway mucus hypersecretion, our study showing AEC-PPARγ’s role as a transcriptional repressor of MUC5AC highlights this receptor’s potential as a pharmacological target for asthma.
登录
查看更多内容
DOI:
10.1056/nejmra0910061
发表时间:
2010-12-02
期刊:
The New England journal of medicine
影响因子:
--
作者:
Fahy JV;Dickey BF
通讯作者:
Dickey BF
影响因子:
2.9
作者:
Shen Y;Chen L;Wang T;Wen F
通讯作者:
Wen F
影响因子:
1.2
作者:
Reddy, Aravind T.;Lakshmi, Sowmya P.;Reddy, Raju C.
通讯作者:
Reddy, Raju C.
影响因子:
5.8
作者:
Narala VR;Ranga R;Smith MR;Berlin AA;Standiford TJ;Lukacs NW;Reddy RC
通讯作者:
Reddy RC
影响因子:
78.5
作者:
Kufe, Donald W.
通讯作者:
Kufe, Donald W.